Invesco Nasdaq Biotechnol... (IBBQ)
NASDAQ: IBBQ
· Real-Time Price · USD
24.95
0.64 (2.62%)
At close: Oct 01, 2025, 3:59 PM
24.94
-0.05%
Pre-market: Oct 02, 2025, 08:24 AM EDT
2.62% (1D)
| Bid | 23.68 |
| Market Cap | 37.13M |
| AUM | 37.4M |
| NAV | 23.8 |
| EPS (ttm) | 0.86 |
| PE Ratio (ttm) | 29.09 |
| Shares Out | 1.49M |
| Inception Date | Jun 10, 2021 |
| Ask | 26 |
| Volume | 13,356 |
| Open | 24.55 |
| Previous Close | 24.31 |
| Day's Range | 24.47 - 25.08 |
| 52-Week Range | 17.84 - 25.08 |
| Holdings | 253 |
| Expense Ratio | 0.19% |
About IBBQ
The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December.
Asset Class Equity
Ticker Symbol IBBQ
Inception Date Jun 10, 2021
Provider Invesco
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 46.17% of assets
| Name | Symbol | Weight |
|---|---|---|
| Gilead Sciences, Inc... | GILD | 7.78% |
| Vertex Pharmaceutica... | VRTX | 7.74% |
| Amgen Inc. | AMGN | 7.44% |
| Regeneron Pharmaceut... | REGN | 5.52% |
| Alnylam Pharmaceutic... | ALNY | 5.50% |
| Astrazeneca PLC | AZN | 3.62% |
| Insmed Incorporated | INSM | 2.75% |
| Argenx Se | ARGX | 2.06% |
| Biogen Inc. | BIIB | 1.91% |
| United Therapeutics ... | UTHR | 1.85% |
Dividends Dividend Yield 0.94%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Sep 22, 2025 | $0.0958 | Sep 26, 2025 |
| Jun 23, 2025 | $0.0287 | Jun 27, 2025 |
| Mar 24, 2025 | $0.0402 | Mar 28, 2025 |
| Dec 23, 2024 | $0.0619 | Dec 27, 2024 |
| Sep 23, 2024 | $0.0894 | Sep 27, 2024 |
